NASDAQ:INNV - Nasdaq - US45784A1043 - Common Stock - Currency: USD
2.75
-0.09 (-3.17%)
The current stock price of INNV is 2.75 USD. In the past month the price decreased by -15.38%. In the past year, price decreased by -30.38%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 12.07 | 89.50B | ||
CVS | CVS HEALTH CORP | 12.42 | 84.95B | ||
DGX | QUEST DIAGNOSTICS INC | 18.16 | 18.28B | ||
LH | LABCORP HOLDINGS INC | 14.9 | 18.17B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 12.78 | 13.88B | ||
DVA | DAVITA INC | 14.74 | 11.20B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.15 | 10.60B | ||
CHE | CHEMED CORP | 25.14 | 8.50B | ||
HIMS | HIMS & HERS HEALTH INC | 50.43 | 6.05B | ||
CRVL | CORVEL CORP | 27.53 | 5.91B | ||
GH | GUARDANT HEALTH INC | N/A | 5.55B | ||
OPCH | OPTION CARE HEALTH INC | 26.25 | 5.26B |
InnovAge Holding Corp. engages in managing the care of high-cost, frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). The company is headquartered in Denver, Colorado and currently employs 2,350 full-time employees. The company went IPO on 2021-03-04. The firm is focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. The firm's programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its Program of All-Inclusive Care for the Elderly (PACE) program, it fulfills a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan.
INNOVAGE HOLDING CORP
8950 E. Lowry Boulevard
Denver COLORADO 80230 US
CEO: Maureen Hewitt
Employees: 2350
Company Website: https://www.innovage.com/
Investor Relations: http://investor.innovage.com/
Phone: 13038694664
The current stock price of INNV is 2.75 USD. The price decreased by -3.17% in the last trading session.
The exchange symbol of INNOVAGE HOLDING CORP is INNV and it is listed on the Nasdaq exchange.
INNV stock is listed on the Nasdaq exchange.
10 analysts have analysed INNV and the average price target is 5.95 USD. This implies a price increase of 116.36% is expected in the next year compared to the current price of 2.75. Check the INNOVAGE HOLDING CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
INNOVAGE HOLDING CORP (INNV) has a market capitalization of 371.91M USD. This makes INNV a Small Cap stock.
INNOVAGE HOLDING CORP (INNV) currently has 2350 employees.
INNOVAGE HOLDING CORP (INNV) has a resistance level at 2.81. Check the full technical report for a detailed analysis of INNV support and resistance levels.
The Revenue of INNOVAGE HOLDING CORP (INNV) is expected to grow by 12.13% in the next year. Check the estimates tab for more information on the INNV EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
INNV does not pay a dividend.
INNOVAGE HOLDING CORP (INNV) will report earnings on 2025-05-13, after the market close.
INNOVAGE HOLDING CORP (INNV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.12).
The outstanding short interest for INNOVAGE HOLDING CORP (INNV) is 1.83% of its float. Check the ownership tab for more information on the INNV short interest.
ChartMill assigns a fundamental rating of 2 / 10 to INNV. Both the profitability and financial health of INNV have multiple concerns.
Over the last trailing twelve months INNV reported a non-GAAP Earnings per Share(EPS) of -0.12. The EPS increased by 47.83% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -4.9% | ||
ROE | -10.36% | ||
Debt/Equity | 0.28 |
ChartMill assigns a Buy % Consensus number of 48% to INNV. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 10.15% and a revenue growth 12.13% for INNV